Clinical Trial Results

clinical-trial-results3

Utilizing both clinical objective measurements and consumer evaluations, the trial strongly demonstrated that ECM9™ was highly effective across all 6 key measures of skin aging. Dramatic results were observed with statistically significant clinical improvements. This highly effective multi-action ingredient dramatically reduced the appearance of multiple signs of aging.

  • 80% of participants showed improvements in skin texture that was statistically significant through 8 weeks
  • 86% of participants showed statistically significant improvements in fine lines/wrinkles after 2 weeks
  • 95% of participants showed statistically significant improvements in skin firmness/elasticity within 4 weeks
  • 80% of participants showed improvement in skin clarity that was statistically significant through 8 weeks
  • 80% of participants showed improvement in radiance and luminosity at week 4 that was statistically significant over baseline
  • 95% of participants showed improvement in skin moisture at week 2 that was statistically significant over baseline
Consumer Evaluations Results:

The participants were invited to make their own evaluations of the effects of ECM9™. Between 90-100% of them observed significant improvements across all 6 measures of skin aging.

  • Skin Texture: 100% noticed significant improvement
  • Fine Lines/Wrinkles:90% saw significant improvement
  • Firmness/Elasticity: 95% noticed significant improvement
  • Skin Clarity: 95% saw significant improvement
  • Radiance/Luminosity: 100% saw significant improvement
  • Skin Moisture: 95% saw significant improvement
Conclusions

Keprea has tested and proven that ECM9™ is a highly potent multi-action ingredient that has been proven clinically to significantly improve all 6 key signs of aging.

Intellectual Property

Keprea, LLC holds the exclusive worldwide rights to the ECM9™ patents.